Impact of Respiratory Viral Infections in Transplant Recipients

© The Author(s) 2024. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..

Respiratory viral infections (RVIs) are among the leading cause of morbidity and mortality in pediatric hematopoietic stem cell transplant (HCT) and solid organ transplant (SOT) recipients. Transplant recipients remain at high risk for super imposed bacterial and fungal pneumonia, chronic graft dysfunction, and graft failure as a result of RVIs. Recent multicenter retrospective studies and prospective studies utilizing contemporary molecular diagnostic techniques have better delineated the epidemiology and outcomes of RVIs in pediatric transplant recipients and have advanced the development of preventative vaccines and treatment interventions in this population. In this review, we will define the epidemiology and outcomes of RVIs in SOT and HSCT recipients, describe the available assays for diagnosing a suspected RVI, highlight evolving management and vaccination strategies, review the risk of donor derived RVI in SOT recipients, and discuss considerations for delaying transplantation in the presence of an RVI.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

Journal of the Pediatric Infectious Diseases Society - 13(2024), Supplement_1 vom: 28. Feb., Seite S39-S48

Sprache:

Englisch

Beteiligte Personen:

Bahakel, Hannah [VerfasserIn]
Waghmare, Alpana [VerfasserIn]
Madan, Rebecca Pellet [VerfasserIn]

Links:

Volltext

Themen:

Hematopoietic transplantation
Journal Article
Review
Solid organ transplantation
Viral respiratory infection

Anmerkungen:

Date Completed 01.03.2024

Date Revised 01.03.2024

published: Print

Citation Status MEDLINE

doi:

10.1093/jpids/piad094

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369069994